• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    InflaRx N.V. - Common Stock (NQ:IFRX)

    1.995 +0.035 (+1.79%)
    Streaming Delayed Price Updated: 3:00 PM EDT, Aug 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 304,208
    Open 1.990
    Bid (Size) 1.990 (2,000)
    Ask (Size) 2.000 (6,600)
    Prev. Close 1.960
    Today's Range 1.920 - 2.020
    52wk Range 0.7790 - 2.949
    Shares Outstanding 44,203,763
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InflaRx (NASDAQ:IFRX) Tumbles After Q2 Results Miss Estimates ↗
    Via Chartmill
    News headline image
    InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
    From InflaRx N.V.
    Via GlobeNewswire

    Performance

    YTD
    +83.0%
    +83.0%
    1 Month
    -3.2%
    -3.2%
    3 Month
    -20.2%
    -20.2%
    6 Month
    +132.6%
    +132.6%
    1 Year
    +142.4%
    +142.4%

    More News

    Read More
    News headline image
    InflaRx to Report Second Quarter 2026 Results on August 6, 2026
    From InflaRx N.V.
    Via GlobeNewswire
    News headline image
    InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
    From InflaRx N.V.
    Via GlobeNewswire
    News headline image
    InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and Renal Disease Pipeline ↗
    Via MarketBeat
    IFRX Stock Soars Pre-Market After Experimental Drug Shows Promise In Treating Chronic Skin Diseases ↗
    Via Stocktwits
    News headline image
    InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
    From InflaRx N.V.
    Via GlobeNewswire
    News headline image
    InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
    From InflaRx N.V.
    Via GlobeNewswire
    News headline image
    InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
    From InflaRx N.V.
    Via GlobeNewswire
    Friday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Is InflaRx NV Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    Earnings Season: Synergy CHC (NASDAQ: SNYR) FOCUSfactor® Beverage – Eyes $100M+ in 2026 – More Stocks Reporting Inside
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    These stocks are the most active in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Biogen's Immunology Pipeline Has Long-Term Potential: Analyst ↗
    Via Benzinga

    Frequently Asked Questions

    Is InflaRx N.V. - Common Stock publicly traded?
    Yes, InflaRx N.V. - Common Stock is publicly traded.
    What exchange does InflaRx N.V. - Common Stock trade on?
    InflaRx N.V. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for InflaRx N.V. - Common Stock?
    The ticker symbol for InflaRx N.V. - Common Stock is IFRX on the Nasdaq Stock Market
    What is the current price of InflaRx N.V. - Common Stock?
    The current price of InflaRx N.V. - Common Stock is 1.995
    When was InflaRx N.V. - Common Stock last traded?
    The last trade of InflaRx N.V. - Common Stock was at 08/11/26 03:00 PM ET
    What is the market capitalization of InflaRx N.V. - Common Stock?
    The market capitalization of InflaRx N.V. - Common Stock is 88.19M
    How many shares of InflaRx N.V. - Common Stock are outstanding?
    InflaRx N.V. - Common Stock has 88M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.